CIK 0001771910 · Non-accelerated filer<br>Smaller reporting company
ADC Therapeutics SA
Sign in to watch- Ticker
- ADCT
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- Phone
- 41 21 653 02 00
- Business address
- BIOPOLE, ROUTE DE LA CORNICHE 3B, EPALINGES, Switzerland, 1066
- 4 Open-market sale Director sold 6,995 shares at $2.89 ($20,216)
- 4 Open-market sale Director sold 6,995 shares at $2.89 ($20,216)
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Executive Officer sold 29,731 shares at $4.48 ($133,195)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 4 of 5 · 88 filings